Sue Wang, a partner at Sidley Austin LLP, has established herself as a formidable presence in the field of intellectual property litigation, particularly within the life sciences sector. Her legal acumen has been instrumental in securing significant victories for major pharmaceutical and biotechnology companies.
Wang’s representation of Amgen Inc. in complex patent disputes underscores her expertise. Notably, she was part of the legal team in the case of Amgen Inc. v. Sandoz Inc., where Amgen sought to enforce its patents against biosimilar competitors. This case highlighted the intricate challenges in biologics patent litigation and showcased Wang’s ability to navigate such complexities effectively.
In addition to her work with Amgen, Wang has achieved substantial outcomes for Bayer. Her strategic litigation efforts led to a multimillion-dollar verdict in favor of the company, further solidifying her reputation in high-stakes patent litigation.
Wang’s practice encompasses a broad spectrum of technologies, including gene editing, RNA interference, antibody therapeutics, protein manufacturing processes, cancer immunotherapy, and T-cell therapies. Her comprehensive understanding of these areas enables her to provide nuanced counsel to clients navigating the intersection of law and cutting-edge science.
Beyond litigation, Wang advises clients on patent and technology-related matters, such as analyzing patents for technology acquisitions, conducting freedom-to-operate assessments for pipeline products, and strategic planning for future litigation. Her proactive approach ensures that clients are well-prepared to address potential legal challenges in the rapidly evolving life sciences landscape.
Wang’s contributions have not gone unnoticed. She was selected to the Super Lawyers Rising Stars list from 2020 to 2022, an honor that reflects her standing among peers and her impact on the legal community.
Educated at Stanford Law School, Wang has been licensed to practice in California since 2012. She is based in Sidley Austin’s San Francisco office, where she continues to advocate for clients in the life sciences industry, combining her legal expertise with a deep understanding of scientific advancements.